Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Kinematic Technology Helps Treat Patients with Tremors

By HospiMedica International staff writers
Posted on 26 May 2016
A combination of wearable movement sensors and computer software can help clinicians precisely plan where to place botox injections to reduce upper limb tremors at the source.

Developed by researchers at the Lawson Health Research Institute (LHRI; London, ON, Canada), the University of Bonab (Iran), and other institutions, TremorTek is a kinematic tremor assessment system that helps determine exactly which muscles and what biomechanics are at play for each individual patient's tremor symptoms. More...
The data helps alleviate functional disability caused by essential tremor by objectively individualizing and personalizing injection parameters for botulinum toxin type A (BoNT-A).

The researchers conducted a 38-week open label study of 24 people injected with BoNT-A. The participants performed two postural and two weight-bearing scripted tasks with TremorTek motion sensors placed over the wrist, elbow, and shoulder joints. The sensors captured angular tremor amplitude and acceleration joint motion that was segmented into directional components: flexion-extension (F/E) at the elbow, F/E and adduction-abduction at the shoulder, pronation-supination, and radial-ulnar F/E at the wrist.

The multi-joint biomechanical recordings allowed individualized selection and determination of which muscles would contribute to specific upper limb tremor biomechanics and subsequent dosing per participant. The results showed that by week 38, the patients showed a significant decrease in tremor amplitude in the wrist and shoulder joints; 40% participants self-reported mild weakness in injected muscles, but had no interference in arm function. The study was published on April 21, 2016, in PLOS One.

“Very few clinicians inject for tremor because before now, it just didn't work. The injections would only cause weakness,” said senior author Professor Mandar Jog, PhD, of the LHRI department of clinical neurological sciences. “We realize now that was because they didn't know where to inject. The uniqueness of our development is the simplicity of it. It records from multiple joints in a straightforward way.”

BoNT-A intramuscular injections are commonly used to treat various movement disorders, such as focal dystonias, and may provide modest beneficial effects in essential tremor patients who are unresponsive to conventional drugs. The therapy has not been widely adopted due to risk of significant hand and wrist weakness causing functional limb impairment, and therefore proper identification of the dynamics of the tremulous joints is necessary to optimize injection pattern and outcomes.

Related Links:
Lawson Health Research Institute
University of Bonab

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ultrasound Needle Guidance System
SonoSite L25
Half Apron
Demi
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.